Related Experiment Videos
Endogenous heparinase-sensitive anticoagulant activity in human plasma
S Cavari1, L Stramaccia, S Vannucchi
1Institute of General Pathology, University of Firenze, Italy.
Thrombosis Research
|July 15, 1992
Summary
Researchers discovered anticoagulant activity in human plasma after digestion, identifying it as heparin. This finding suggests protein interactions may hinder heparin isolation from plasma.
Area of Science:
- Biochemistry
- Hematology
Background:
- Human plasma contains anticoagulant factors.
- Heparin is a crucial anticoagulant, but its presence and isolation from plasma are challenging.
Purpose of the Study:
- To investigate the nature of anticoagulant activity appearing in human plasma after proteolytic digestion.
- To determine if this activity can be identified as heparin and explore reasons for its difficult isolation.
Main Methods:
- Proteolytic digestion of human plasma.
- Assay of anticoagulant activity using thrombin time.
- Enzymatic digestion with chondroitin ABC lyase, heparan sulfate lyase, and heparin lyase.
- Nitrous acid treatment.
- Ion-exchange chromatography on DEAE-Sephacel.
Main Results:
- An anticoagulant activity, measurable by thrombin time, emerged after plasma digestion.
- The activity exhibited heat stability and resistance to specific lyases, but sensitivity to heparin lyase and nitrous acid, suggesting it is heparin.
- The concentration was estimated at 0.1-0.2 I.U./mL in healthy subjects.
- Chromatography showed the activity eluting at low ionic strength.
Conclusions:
- The study identifies authentic heparin in human plasma following proteolytic digestion.
- The elution profile suggests heparin interacts with other plasma components, potentially proteins or protein fragments, complicating its isolation.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
276
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
276
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Extrinsic and Intrinsic Pathways of Hemostasis
12.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.0K